Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)

Detalles Bibliográficos
Autores principales: Frey, Reiner, Mueck, Wolfgang, Becka, Michael, Kraetzschmar, Joern, Wensing, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363219/
http://dx.doi.org/10.1186/1471-2210-11-S1-P26
_version_ 1782234319475965952
author Frey, Reiner
Mueck, Wolfgang
Becka, Michael
Kraetzschmar, Joern
Wensing, Georg
author_facet Frey, Reiner
Mueck, Wolfgang
Becka, Michael
Kraetzschmar, Joern
Wensing, Georg
author_sort Frey, Reiner
collection PubMed
description
format Online
Article
Text
id pubmed-3363219
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33632192012-05-31 Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) Frey, Reiner Mueck, Wolfgang Becka, Michael Kraetzschmar, Joern Wensing, Georg BMC Pharmacol Poster Presentation BioMed Central 2011-08-01 /pmc/articles/PMC3363219/ http://dx.doi.org/10.1186/1471-2210-11-S1-P26 Text en Copyright ©2011 Frey et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Frey, Reiner
Mueck, Wolfgang
Becka, Michael
Kraetzschmar, Joern
Wensing, Georg
Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title_full Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title_fullStr Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title_full_unstemmed Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title_short Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
title_sort antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (bay 58-2667)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363219/
http://dx.doi.org/10.1186/1471-2210-11-S1-P26
work_keys_str_mv AT freyreiner antiplateleteffectsofaspirinarenotaffectedbythesolubleguanylatecyclaseactivatorcinaciguatbay582667
AT mueckwolfgang antiplateleteffectsofaspirinarenotaffectedbythesolubleguanylatecyclaseactivatorcinaciguatbay582667
AT beckamichael antiplateleteffectsofaspirinarenotaffectedbythesolubleguanylatecyclaseactivatorcinaciguatbay582667
AT kraetzschmarjoern antiplateleteffectsofaspirinarenotaffectedbythesolubleguanylatecyclaseactivatorcinaciguatbay582667
AT wensinggeorg antiplateleteffectsofaspirinarenotaffectedbythesolubleguanylatecyclaseactivatorcinaciguatbay582667

Ejemplares similares